PP01.25 Incidence and Timing of Immune-Related Adverse Events in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitor As Monotherapy or in Combination with Chemotherapy
Journal of Thoracic Oncology(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要